Computational genomic discovery of diverse gene clusters harboring Fe-S flavoenzymes in anaerobic gut microbiota

• Published in: bioRxiv
• Main Authors: Victoria Pascal Andreu, Fischbach, Michael A, Medema, Marnix H
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 06.03.2020; Cold Spring Harbor Laboratory
• Edition: 1.1
• Subjects: Bile; Bile acids; Bioinformatics; Cholic acid; Computer applications; Deoxycholic acid; Enzymes; Food sources; Gene clusters; Genomic analysis; Intestinal microflora; Lipids; Metabolism; Microbiota
• DOI: 10.1101/2020.03.06.976126
• ISSN: 2692-8205

The gut contains an enormous diversity of simple as well as complex molecules from highly diverse food sources as well as host-secreted molecules. This presents a large metabolic opportunity for the gut microbiota, but little is known on how gut microbes are able to catabolize this large chemical diversity. Recently, Fe-S flavoenzymes were found to be key in the transformation of bile acids, catalysing the key step in the 7-dehydroxylation pathway that allows gut bacteria to transform cholic acid (CA) into deoxycholic acid (DCA), an exclusively microbe-derived molecule with major implications for human health. While this enzyme family has also been implicated in a limited number of other catalytic transformations, little is known about the extent to which it is of more global importance in gut microbial metabolism. Here, we use large-scale computational genomic analysis to show that this enzyme superfamily has undergone a remarkable expansion in Clostridiales, and occurs throughout a diverse array of >1,000 different families of putative metabolic gene clusters. Analysis of the enzyme content of these gene clusters suggests that they encode pathways with a wide range of predicted substrate classes, including saccharides, amino acids/peptides and lipids. Altogether, these results indicate a potentially important role of this protein superfamily in the human gut, and our dataset provides significant opportunities for the discovery of novel pathways that may have significant effects on human health.